159 related articles for article (PubMed ID: 593431)
1. Desipramine and some other antidepressant drugs decrease the major norepinephrine metabolite 3,4-dihydroxyphenylglycol-sulphate in the rat brain.
Nielsen M; Braestrup C
Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):93-9. PubMed ID: 593431
[No Abstract] [Full Text] [Related]
2. Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain.
Nielsen M; Braestrup C
Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):87-92. PubMed ID: 593430
[No Abstract] [Full Text] [Related]
3. [Histochemical study of the effect of drugs on the uptake of alpha-methylnoradrenaline by noradrenaline and dopamine containing neurones in rats treated with reserpine].
Lorez HP
Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(3):241-60. PubMed ID: 5358460
[No Abstract] [Full Text] [Related]
4. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
Carlsson A; Fuxe K; Hamberger B; Lindqvist M
Acta Physiol Scand; 1966; 67(3):481-97. PubMed ID: 5967609
[No Abstract] [Full Text] [Related]
5. Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine.
Carlsson A; Corrodi H; Fuxe K; Hökfelt T
Eur J Pharmacol; 1969 Mar; 5(4):367-73. PubMed ID: 5786360
[No Abstract] [Full Text] [Related]
6. Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.
Schildkraut JJ; Schanberg SM; Breese GR; Kopin IJ
Am J Psychiatry; 1967 Nov; 124(5):600-8. PubMed ID: 4383104
[No Abstract] [Full Text] [Related]
7. Storage and synthesis of norepinephrine in the reserpine-treated rat brain.
Glowinski J; Iversen LL; Axelrod J
J Pharmacol Exp Ther; 1966 Mar; 151(3):385-99. PubMed ID: 4380046
[No Abstract] [Full Text] [Related]
8. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
[TBL] [Abstract][Full Text] [Related]
9. Effects of morphine and other centrally acting drugs on 3,4-dihydroxyphenylethylene glycol sulfate (DOPEG-SO4) in rat brain.
Huff JW; Reigle TG
Life Sci; 1980 Oct; 27(16):1483-8. PubMed ID: 7442455
[No Abstract] [Full Text] [Related]
10. Effect of desmethylimipramine, protriptyline and (+)-amphetamine on fluorescence of central adrenergic neurons of rats pretreated with alpha-methyl-DOPA and tetrabenazine or reserpine.
Carlsson A; Fuxe K; Hökfelt T
Eur J Pharmacol; 1967 Dec; 2(3):196-201. PubMed ID: 5590343
[No Abstract] [Full Text] [Related]
11. Action of the antidepressant pridefine (AHR-1118) on biogenic amines in the rat brain.
Vosmer G; DeMet EM; Halaris AE
Biochem Pharmacol; 1980 Oct; 29(19):2557-62. PubMed ID: 7426062
[No Abstract] [Full Text] [Related]
12. Modification by desipramine (DMI) of the availability of norepinephrine released by reserpine in the hypothalamus of the rat in vivo.
Sulser F; Owens ML; Strada SJ; Dingell JV
J Pharmacol Exp Ther; 1969 Aug; 168(2):272-82. PubMed ID: 5803311
[No Abstract] [Full Text] [Related]
13. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
Roffler-Tarlov S
Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
[No Abstract] [Full Text] [Related]
14. Effect of chronic apomorphine on the development of denervation supersensitivity.
Robin M; Forler C; Palfreyman MG
Pharmacol Biochem Behav; 1985 Apr; 22(4):547-51. PubMed ID: 3921992
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.
Waldmeier PC; Maître L
Psychopharmacology (Berl); 1977 Apr; 52(2):137-44. PubMed ID: 407597
[No Abstract] [Full Text] [Related]
16. Effects of L-tyrosine on brain monoamines in rats given intravenous amphetamine.
Smith DG; Geis LS; Lyness WH
Subst Alcohol Actions Misuse; 1984-1985; 5(6):293-8. PubMed ID: 6085821
[TBL] [Abstract][Full Text] [Related]
17. Electron-microscopic localization of tritiated norepinephrine in rat brain: effect of drugs.
Aghajanian GK; Bloom FE
J Pharmacol Exp Ther; 1967 Jun; 156(3):407-16. PubMed ID: 6027453
[No Abstract] [Full Text] [Related]
18. Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens.
Eisenhofer G; Ropchak TG; Stull RW; Goldstein DS; Keiser HR; Kopin IJ
J Pharmacol Exp Ther; 1987 May; 241(2):547-53. PubMed ID: 3572811
[TBL] [Abstract][Full Text] [Related]
19. Assessment of dopamine release by in vivo microdialysis in the nucleus accumbens of rats following acute and chronic administration of desipramine.
See RE; Adams-Curtis L; Chapman MA
Ann N Y Acad Sci; 1992 Jun; 654():522-4. PubMed ID: 1378710
[No Abstract] [Full Text] [Related]
20. In vivo studies on central noradrenergic synaptic mechanisms after acute and chronic antidepressant drug treatment: biochemical and behavioral comparison.
Racagni G; Mocchetti I; Renna G; Cuomo V
J Pharmacol Exp Ther; 1982 Oct; 223(1):227-34. PubMed ID: 7120121
[No Abstract] [Full Text] [Related]
[Next] [New Search]
